Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin : a prospective study

Bloemendaal, A L A ; Verwaal, V J LU ; van Ruth, S ; Boot, H and Zoetmulder, F A N (2005) In European Journal of Surgical Oncology 31(10). p.1145-1151
Abstract

AIMS: To report the results of standard therapy for peritoneal carcinomatosis of colorectal origin, which consists of conventional surgery and systemic chemotherapy.

METHOD: In a prospective study 50 patients with proven peritoneal carcinomatosis of colorectal origin were treated with conventional surgery combined with 5-fluorouracil and leucovorin, or irinotecan in patients treated by 5-fluorouracil within 12 months prior to entry. Survival and progression-free survival were studied and prognostic factors were analysed.

RESULTS: The median survival time was 12.6 months. The median time to progression was 7.6 months. Location of primary tumour and result of conventional surgery and systemic chemotherapy were prognostic... (More)

AIMS: To report the results of standard therapy for peritoneal carcinomatosis of colorectal origin, which consists of conventional surgery and systemic chemotherapy.

METHOD: In a prospective study 50 patients with proven peritoneal carcinomatosis of colorectal origin were treated with conventional surgery combined with 5-fluorouracil and leucovorin, or irinotecan in patients treated by 5-fluorouracil within 12 months prior to entry. Survival and progression-free survival were studied and prognostic factors were analysed.

RESULTS: The median survival time was 12.6 months. The median time to progression was 7.6 months. Location of primary tumour and result of conventional surgery and systemic chemotherapy were prognostic factors related to survival.

CONCLUSION: The survival time of patients with peritoneal carcinomatosis of colorectal origin seems to be increased in patients treated by conventional surgery and systemic chemotherapy when compared to minimal treatment.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; and
publishing date
type
Contribution to journal
publication status
published
keywords
Adult, Aged, Antineoplastic Agents/therapeutic use, Colorectal Neoplasms/drug therapy, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Peritoneal Neoplasms/drug therapy, Prognosis, Prospective Studies, Survival Analysis
in
European Journal of Surgical Oncology
volume
31
issue
10
pages
7 pages
publisher
Elsevier
external identifiers
  • pmid:16084051
  • scopus:29244491447
ISSN
0748-7983
DOI
10.1016/j.ejso.2005.06.002
language
English
LU publication?
no
id
d6bcf87d-ccbc-4668-aa2e-dab8a4afa99a
date added to LUP
2022-04-12 10:47:01
date last changed
2025-01-02 01:13:16
@article{d6bcf87d-ccbc-4668-aa2e-dab8a4afa99a,
  abstract     = {{<p>AIMS: To report the results of standard therapy for peritoneal carcinomatosis of colorectal origin, which consists of conventional surgery and systemic chemotherapy.</p><p>METHOD: In a prospective study 50 patients with proven peritoneal carcinomatosis of colorectal origin were treated with conventional surgery combined with 5-fluorouracil and leucovorin, or irinotecan in patients treated by 5-fluorouracil within 12 months prior to entry. Survival and progression-free survival were studied and prognostic factors were analysed.</p><p>RESULTS: The median survival time was 12.6 months. The median time to progression was 7.6 months. Location of primary tumour and result of conventional surgery and systemic chemotherapy were prognostic factors related to survival.</p><p>CONCLUSION: The survival time of patients with peritoneal carcinomatosis of colorectal origin seems to be increased in patients treated by conventional surgery and systemic chemotherapy when compared to minimal treatment.</p>}},
  author       = {{Bloemendaal, A L A and Verwaal, V J and van Ruth, S and Boot, H and Zoetmulder, F A N}},
  issn         = {{0748-7983}},
  keywords     = {{Adult; Aged; Antineoplastic Agents/therapeutic use; Colorectal Neoplasms/drug therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Peritoneal Neoplasms/drug therapy; Prognosis; Prospective Studies; Survival Analysis}},
  language     = {{eng}},
  number       = {{10}},
  pages        = {{1145--1151}},
  publisher    = {{Elsevier}},
  series       = {{European Journal of Surgical Oncology}},
  title        = {{Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin : a prospective study}},
  url          = {{http://dx.doi.org/10.1016/j.ejso.2005.06.002}},
  doi          = {{10.1016/j.ejso.2005.06.002}},
  volume       = {{31}},
  year         = {{2005}},
}